ArticleESC heart failure2022
Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction.
Abstract readEditorial
In one paragraph
Article in ESC heart failure, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.
0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed.
- Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction.European heart journal · 2025Trial
- Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.Nature medicine · 2026Article
- Extent and predictors of guideline-directed medical therapy optimization during cardiac rehabilitation in patients with heart failure.International journal of cardiology. Cardiovascular risk and prevention · 2026Article
- Heart Failure and Comorbidities (Chronic Kidney Disease, Diabetes, Obesity) Management: A Multidisciplinary Approach.Cardiorenal medicine · 2026Review
- Comparative Mortality in Heart Failure on Guideline-Directed Medical Therapy Versus Malignant Cancer: A Report From a Global Federated Research Network.Journal of the American Heart Association · 2025Article
- Rapid and Simultaneous Initiation of Guideline-Directed Kidney Therapies in Patients with CKD and Type 2 Diabetes.Journal of the American Society of Nephrology : JASN · 2025 · on this mapReview
- Article
- Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence.ESC heart failure · 2025Review
- Is It Safe to Initiate/Optimize the Medication of HFrEF Patients During Hospitalization for Acute Decompensation?Journal of clinical medicine · 2025Article
- Assessing the application of American Heart Association (AHA) guidelines in the management of heart failure with reduced ejection fraction.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025Article
- Examining the clinical role and educational preparation of heart failure nurses across Europe. A survey of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP) of the ESC.European journal of heart failure · 2025Article
- Heart failure in Europe: Guideline-directed medical therapy use and decision making in chronic and acute, pre-existing and de novo, heart failure with reduced, mildly reduced, and preserved ejection fraction - the ESC EORP Heart Failure III Registry.European journal of heart failure · 2024Article
- Sodium Zirconium Cyclosilicate for Renin-Angiotensin-Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis.Cardiology and therapy · 2024Article
- Heart failure treatment in the last years of life: A nationwide study of 364 000 individuals.European journal of heart failure · 2024Article
- Strategy for an early simultaneous introduction of four-pillars of heart failure therapy: results from a single center experience.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024Observational
- High-intensity care for GDMT titration.Heart failure reviews · 2024Review
- Initiation and Up-titration of Guideline-directed Medical Therapy for Patients with Heart Failure: Better, Faster, Stronger!Cardiac failure review · 2024Review
- Heart Failure Nurses within the Primary Care Setting.Cardiac failure review · 2024Review
- Optimizing outcomes in heart failure: 2022 and beyond.ESC heart failure · 2023Review
- Metabolic Approaches for the Treatment of Dilated Cardiomyopathy.Journal of cardiovascular development and disease · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Nicolas GirerdUniversité de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, CHRU Nancy, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), 4 Rue du Morvan, 54500 Vandoeuvre lès, Nancy, France.ORCID 0000-0002-3278-2057
Jean-Jacques Von HunolsteinDivision of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
Pierpaolo PellicoriRobertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, UK.
Antoni Bayés-GenísCIBERCV, Servicio de Cardiología, Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Barcelona, Spain.
Tiny JaarsmaDepartment of Health, Medicine and Caring, Linköping University, Linköping, Sweden.
Lars H LundDepartment of Medicine, Karolinska Institutet, and Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden.
Pascal BilbaultEmergency Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Jean-Marc BoivinUniversité de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, CHRU Nancy, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), 4 Rue du Morvan, 54500 Vandoeuvre lès, Nancy, France.
Tahar ChouihedEmergency Department, University Hospital of Nancy, Nancy, France.
Jérôme CostaPôle vasculaire, service de cardiologie, centre hospitalo-universitaire de Reims, Reims, France.
Jean-Christophe EicherDepartment of Cardiology, CHU Dijon, Dijon, France.
Estelle FallUniversité de Lorraine, APEMAC, Metz, France.
David KenizouDepartment of Cardiology, Hôpital Emile Muller, Mulhouse, France.
Bruno MaillierService de cardiologie, Centre hospitalier de Troyes, Troyes, France.
Pierre NazeyrollasPôle vasculaire, service de cardiologie, centre hospitalo-universitaire de Reims, Reims, France.
Gérald RoulUnité Fonctionnelle Dédiée à L'insuffisance Cardiaque, Pôle Médical et Chirurgical des Maladies Cardio-vasculaires, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Noura ZannadDepartment of Cardiology, Regional Hospital, Mercy Hospital, Metz, France.
Patrick RossignolUniversité de Lorraine, INSERM, Centre d'Investigations Cliniques-Plurithématique 1433, CHRU Nancy, and INSERM U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), 4 Rue du Morvan, 54500 Vandoeuvre lès, Nancy, France.
Marie-France SerondeDepartment of Cardiology, University Hospital Besançon, Besançon, France.
EF-HF Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Heart FailureVentricular Dysfunction, LeftHumansStroke Volume
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.